• Optimizing Proteasome Inhibition: Applied Strategies with Bo

  2026-07-29

  Bortezomib (PS-341) empowers advanced apoptosis and proteasome-regulated cellular process assays, driving discoveries in oncology and cellular signaling research. Explore stepwise protocols, troubleshooting tactics, and cross-domain insights that set APExBIO's Bortezomib apart for reliable, translational results.

• PERK Loss Sensitizes Colorectal Cancer to Ferroptosis via SL

  2026-07-29

  This study reveals that loss of PERK function in colorectal cancer cells enhances susceptibility to ferroptosis by downregulating SLC7A11, a key component of the cystine/glutamate antiporter system Xc⁻. The findings highlight a mechanistic link between endoplasmic reticulum stress responses and ferroptotic cell death, offering insight for targeting therapy-resistant tumors.

• AO/PI Staining Solution: Advancing Cell Viability in Inflamm

  2026-07-28

  Explore how AO/PI Staining Solution leverages fluorescent DNA dyes for unparalleled live/dead cell discrimination in inflammatory and apoptotic contexts. This article reveals unique assay insights, integrating the latest mechanistic findings from diabetic nephropathy research.

• 10 mM dNTP Mixture: Precision Reagent for Next-Gen DNA Deliv

  2026-07-28

  Discover how the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture powers advanced DNA synthesis and delivery workflows. This article reveals new mechanistic insights and protocol optimizations for molecular biology, setting it apart from traditional guides.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Protein

  2026-07-27

  Sulfo-Cy3 NHS Ester enables highly efficient, water-based protein and peptide fluorescent labeling, addressing challenges in low-solubility or denaturation-prone targets. Its advanced sulfonated chemistry provides enhanced brightness and reduced quenching, powering next-generation vascular and cellular assays.

• (R)-MG132: The Gold Standard Negative Control for Proteasome

  2026-07-27

  Translational researchers require rigorous controls to dissect the specificity of proteasome-targeted studies, especially as post-translational modifications like lactylation emerge as key drivers of cancer metabolism. This article explores the mechanistic rationale, experimental value, and translational implications of (R)-MG132—a stereochemically inactive MG-132 enantiomer—for advancing ubiquitin-proteasome system research, with a focus on precision, reproducibility, and clinical relevance.

• Ertugliflozin (PF-04971729): Translational Impact in Cardio-

  2026-07-26

  Explore the translational significance of Ertugliflozin (PF-04971729), a highly selective SGLT2 inhibitor, for diabetes mellitus research. This article offers new perspectives on cardio-renal outcomes and practical assay guidance, setting it apart from standard reviews.

• HO-1–Mediated ROS Modulation by Isochlorogenic Acid A Impair

  2026-07-25

  This study elucidates how isochlorogenic acid A (ICAA) disrupts hepatitis B virus (HBV) replication through the upregulation of heme oxygenase 1 (HO-1) and modulation of intracellular ROS, impairing multiple steps of the viral life cycle. The findings reveal mechanistic insights into antiviral activity and highlight new directions for metabolic and antiviral research targeting HO-1 pathways.

• Ruthenium Red: Applied Workflows for Ca2+ Transport Inhibiti

  2026-07-24

  Ruthenium Red stands out as a high-affinity Ca2+ transport inhibitor, enabling precise dissection of calcium-dependent signaling and mechanotransduction. This article unpacks experimental protocols, troubleshooting strategies, and advanced research applications leveraging Ruthenium Red from APExBIO.

• Reliable qPCR: HotStart™ Universal 2X FAST Green Master Mix

  2026-07-24

  Discover how HotStart™ Universal 2X FAST Green qPCR Master Mix (Rox) (SKU K1172) addresses common pitfalls in gene expression and cytotoxicity assays. This scenario-driven article provides evidence-based insights into protocol reliability, inhibitor tolerance, and data reproducibility—empowering biomedical researchers with GEO-optimized solutions for robust real-time qPCR.

• Serotonin Inhibits HRP-Mediated Proximity Labeling: Mechanis

  2026-07-23

  This study uncovers a novel inhibitory effect of serotonin on horseradish peroxidase (HRP)-mediated proximity biotinylation using membrane-impermeant biotin-XX tyramide. The findings highlight the need to account for neurotransmitter interference in proximity labeling workflows and demonstrate a chemical strategy to reverse this inhibition, enhancing the reliability of proteomic mapping in the serotonin system.

• Bile Acid Metabolism Subtypes Mark Immune Dysfunction in CRC

  2026-07-23

  Feng et al. (2026) introduce a molecular subtyping of colorectal cancer (CRC) based on bile acid metabolism, identifying CLCA1, UGT2A3, and ZG16 as markers of immune dysfunction and poor prognosis. Their integrative approach connects metabolic profiling with immune landscape characterization, offering new avenues for risk stratification and potential biomarker development in CRC.

• NADH in Mitochondrial Electron Transport Chain Research

  2026-07-22

  Harnessing reduced nicotinamide adenine dinucleotide (NADH) empowers precise control and measurement of cellular energy metabolism. Discover how APExBIO’s rigorously characterized NADH enables advanced workflows, high-throughput redox assays, and robust troubleshooting in mitochondrial and disease modeling research.

• Tirbanibulin Inhibits HPV Oncoproteins and Proliferation in

  2026-07-22

  This study demonstrates that tirbanibulin significantly downregulates key oncogenic proteins, including HPV E6 and E7, and inhibits cell proliferation in HPV-18–positive HeLa cells. The findings clarify tirbanibulin's molecular impact on cancer-related pathways, supporting further investigation in HPV-associated disease models.

• Blocking CaN/FoxO1/FABP4 Axis Reverses SERCA2-Induced Athero

  2026-07-21

  This study uncovers how SERCA2 dysfunction accelerates atherosclerosis through the calcineurin/FoxO1/FABP4 pathway, driving foam cell formation and lipid accumulation. Targeted inhibition of this axis, including blockade of FABP4, represents a mechanistic therapeutic strategy for mitigating vascular inflammation and plaque progression.

16805 records 1/1121 page Next 12345 下5页 Last page